Effect of naloxone, haloperidol and propranolol on cyclic 3',5'-adenosine monophosphate content of rat amygdala.
Naloxone (0.4 mg/kg, i.p.) causes an increase of cyclic adenosine monophosphate levels in the amygdala, but not in the hippocampus, caudate, or hypothalamus, of rats. The effect is antagonized by haloperidol (0.5 mg/kg, i.p.) and by propranolol (0.5 mg/kg, i.p.). This is consistent with the hypothesis of a tonic inhibitory influence of endogenous opiates on central dopaminergic and beta-noradrenergic systems. Haloperidol had an effect of its own on amygdala cyclic adenosine monophosphate levels which was blocked by propranolol. This suggests the possibility of an antagonistic interaction between dopaminergic and beta-noradrenergic innervation on this structure.
D000679:Amygdala / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002421:Caudate Nucleus / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism*; D004347:Drug Interactions; D005260:Female; D006220:Haloperidol / Q000494:pharmacology*; D006624:Hippocampus / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D066298:In Vitro Techniques; D009270:Naloxone / Q000494:pharmacology*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats
D009419:Nerve Tissue Proteins; D009270:Naloxone; D011433:Propranolol; D000242:Cyclic AMP; D006220:Haloperidol